(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Analysts: CRBU, SOPA, SNDX, TOST, BLFS, CMC, HVT, NWL, HLMN are a Buy

July 12th, 2023

Caribou Biosciences, Inc. (Nasdaq: CRBU), a company that operates in the field of genome editing and develops CRISPR-based technologies for various applications, was initiated with a Buy rating by Truist, accompanied by a price target of $23.  . Read more

Lockheed Martin Bags $99M Contract; Nasdaq Notifies Enochian Biosciences

July 11th, 2023

Lockheed Martin Rotary and Mission Systems, a business segment of Lockheed Martin Corporation (NYSE: LMT), has been awarded a firm-fixed-price, cost-plus-fixed-fee, indefinite-delivery/indefinite-quantity contract worth up to $99 million. The cont. Read more

Breaking: Shift Technologies' Strategic Move, Delta Air Lines' Key Upcoming Date

July 11th, 2023

Shift Technologies, Inc. (Nasdaq: SFT) plans to restructure its workforce to align with its omnichannel sales strategy, aimed to enhance the customer experience, increase efficiency, and focus on core operations by eliminating investment in the deale. Read more

SEC Charges Merrill Lynch and Parent Company for Failing to File Suspicious Activity Reports

July 11th, 2023

FOR IMMEDIATE RELEASE 2023-128 Washington D.C. / CRWE PRESS RELEASE / July 11, 2023   -   The Securities and Exchange Commission today announced charges against Merrill Lynch, Pierce, Fenner & Smith Incorporated and its parent. Read more

Byrna's Q2 Results Disappoint, electroCore Expects Upbeat Q2 Revenue

July 11th, 2023

Byrna Technologies Inc. (Nasdaq: BYRN) reported a second-quarter fiscal 2023 loss of $0.05 per share and revenue of $11.51 million. These figures fell short of the consensus estimate, which projected earnings per share of $0.01 on revenue of $12 mill. Read more

R100 Vector Deal Fuels 4DMT; ADC Therapeutics Tumbles On ZYNLONTA Trial Status

July 11th, 2023

Astellas Pharma Inc. and 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT)(4DMT) have entered into a license agreement, allowing the use of 4DMT's intravitreal retinotropic R100 vector for rare monogenic ophthalmic diseases. This includes one initial ge. Read more

AspyreRx's Approval Boosts Better Therapeutics; Financial Figures, Outlook Drive WD-40, E2open

July 11th, 2023

Shares of Better Therapeutics, Inc. (Nasdaq: BTTX) surged over 20% in after-hours trading as the company received authorization from the FDA for its groundbreaking prescription-only digital therapeutic, AspyreRx. This innovative treatment offers cogn. Read more

CalAmp Posts Loss, Eyes Strategic Options; PriceSmart Posts Mixed Financial Figures

July 10th, 2023

CalAmp Corp. (Nasdaq: CAMP) faced a first-quarter fiscal 2024 loss of $0.11 per share, falling short of the consensus earnings per share estimate of $0.04. Looking ahead, the company expects Q2 FY24 revenues to range between $67 million and $73 mi. Read more

Market Surges: Mobilicom and Novavax See Dramatic Upswing

July 10th, 2023

Shares of Mobilicom Limited (Nasdaq: MOB) climbed over 100% in early trade following the company's announcement of a significant commercial-scale purchase order from Teledyne-FLIR, one of its Tier-1 customers. The purchase order from Teledyne Tech. Read more

Market Turmoil: FMC Slumps on Lowered Revenue Outlook

July 10th, 2023

Shares of FMC Corporation (NYSE: FMC) plummeted over 6% following the release of an update on its second quarter and full-year 2023 outlook. The company now expects second-quarter revenue to be in the range of $1.00 billion to $1.03 billion, signific. Read more